Sanofi-Aventis, the French drug maker, publicly disclosed its $18.5 billion bid for the American biotechnology firm Genzyme on Sunday, upping the ante in its effort to take over the company.
By ANDREW ROSS SORKIN, NY Times: Business
Sun, 08/29/2010 - 10:00am
Sanofi-Aventis, the French drug maker, publicly disclosed its $18.5 billion bid for the American biotechnology firm Genzyme on Sunday, upping the ante in its effort to take over the company.